Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis

@article{Bhat2018EpigeneticBO,
  title={Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis},
  author={Venkataramana Bhat and Sujitha Srinathan and Elisa Pasini and Marc Angeli and Emily Chen and Cristina Baciu and Mamatha Bhat},
  journal={World Journal of Hepatology},
  year={2018},
  volume={10},
  pages={155 - 165}
}
AIM To identify the key epigenetically modulated genes and pathways in HCC by performing an integrative meta-analysis of all major, well-annotated and publicly available methylation datasets using tools of network analysis. METHODS PubMed and Gene Expression Omnibus were searched for genome-wide DNA methylation datasets. Patient clinical and demographic characteristics were obtained. DNA methylation data were integrated using the Ingenuity Pathway Analysis, a software package for visualizing… 

Figures and Tables from this paper

TET3 Promotes HCC Proliferation And Metastasis Via lncRNA ARAP1-AS1
TLDR
TET3 promoted the proliferation and metastasis of HCC cells by regulating the expression of lncRNA ARAP1-AS1, a well identified onco-lncRNA in several cancer types, as a candidate downstream mediator of TET3.
Integrative Analysis of DNA Methylation and microRNA Expression Reveals Mechanisms of Racial Heterogeneity in Hepatocellular Carcinoma
TLDR
Evaluating the epigenetic mechanisms of racial heterogenity in HCC through an integrated analysis of DNA methylation, miRNA, and combined regulation of gene expression found that the methylome was drastically changed in EA with a significantly larger number of differentially methylated and differentially expressed genes than in AA.
Genome-Wide Open Chromatin Methylome Profiles in Colorectal Cancer
TLDR
Many open chromatin loci with novel differential methylation statuses are reported, some of which with the potential as candidate markers for diagnostic purposes, including OPLAH cg26256223 hypermethylation, which is associated with reduced gene expression in the CRC.
Epigenetic remodelling in human hepatocellular carcinoma
TLDR
The state-of-the-art knowledge about the epigenetic landscape in hepatocarcinogenesis is discussed, including evidence on the diagnostic and prognostic role of non-coding RNAs, modifications occurring at the chromatin level, and their role in the era of precision medicine.
Epigenetics of hepatocellular carcinoma
TLDR
In this review, a concise discussion on recent progress in the field of liver cancer epigenetics and some of the current works that contribute to the progress of Liver cancer therapeutics are presented.
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
TLDR
Sorafenib/BEZ235 combination has potent anti-HCC cell activity that is most likely multi-factorial, mainly involving PI3K down-regulation and AKT, mTOR and S6K dephosphorylation.
Identification of NPAC as a novel biomarker and regulator for hepatocellular carcinoma
TLDR
Evaluated the clinical significance and potential role of NPAC in HCC, a new nuclear protein recently implicated in tumor biology, to find out if it is a viable treatment option for HCC.
GHR knockdown enhances the sensitivity of HCC cells to sorafenib
TLDR
It is suggested that GHR knockdown enhances the sensitivity of HCC cells to sorafenib, and the inactivation of PI3K/AKT/ERK1/2 signaling pathway may be the underlying mechanisms.
Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection
TLDR
Understanding of drivers specific to post-SVR hepatocarcinogenesis is still limited, and lack of suitable in vivo and in vitro experimental systems has hampered efforts to examine etiology-specific mechanisms that might serve to answer this question more thoroughly.
...
1
2
...

References

SHOWING 1-10 OF 47 REFERENCES
DNA Methylation Profiling Identifies EYA4 Gene as a Prognostic Molecular Marker in Hepatocellular Carcinoma
TLDR
EYA4 functions as a prognostic molecular marker in HCC and its aberrant hypermethylation and subsequent down-regulation may promote tumor progression.
Identification of Epigenetically Inactivated Genes in Human Hepatocellular Carcinoma by Integrative Analyses of Methylation Profiling and Pharmacological Unmasking
TLDR
Several potential TSGs that participate in transcription inactivation through epigenetic interactions in HCC are identified using methylation profiling and pharmacological unmasking of methylated TSGs.
Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer
TLDR
Integrative analysis of genomic and epigenomic regulation provides new insights on the multi-layered pathobiology of hepatocellular carcinoma, which might be helpful in developing precision management for hepato Cell carcinoma patients.
DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma
TLDR
A genome-wide DNA methylation approach merged with array-based gene expression profiles allowed identifying a number of novel, epigenetically regulated candidate tumor-suppressor genes in alcohol-associated hepatocarcinogenesis.
Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma.
TLDR
The bioinformatic analysis of GEO datasets of HCC identified the functional gene sets associated with the genesis and development of H CC, and the key genes that were playing important roles in the maintenance of the molecular network for biological function specific to HCC.
Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
TLDR
Substantial changes of DNA methylation at a genome-wide level were observed in HCC and this work found that the methylation changes could have effect on the signaling networks of Cellular development, Gene expression and Cell death.
Definition of the landscape of promoter DNA hypomethylation in liver cancer.
TLDR
It is found that MBD2 depletion in human HCC and adenocarcinoma cells resulted in suppression of cell growth, anchorage-independent growth and invasiveness as well as an increase in promoter methylation and silencing of several of the genes that are hypomethylated in tumors.
Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
TLDR
Evidence is provided that SMPD3 is a potent tumor suppressor gene that could affect tumor aggressiveness; a reduced level of SM PD3 is an independent prognostic factor for early recurrence of HCC.
Genome‐wide DNA methylation profiles in hepatocellular carcinoma
TLDR
A panel of methylated genes indentified in the current study will be further tested in a large cohort of prospectively collected samples to determine their utility as early biomarkers of HCC.
Reactivating the expression of methylation silenced genes in human cancer
TLDR
The mechanisms of gene silencing by DNA methylation, the techniques used to decipher the complement of methylation-inactivated genes in human cancers, and current and future strategies for reactivating the expression of methylisation-silenced genes are discussed.
...
1
2
3
4
5
...